Dana-Farber Cancer Institute has agreed to pay $15 million in a federal settlement, as the Boston research giant admits that researchers mispresented data and images in scientific journal articles. The settlement resolves allegations that Dana-Farber made false statements related to NIH research grants. Two Dana-Farber scientists — or individuals under their supervision — were accused of using inaccurate or altered data or images in publications that were supported by NIH-funded awards, or in grant applications that resulted in federal funding for additional research. This settlement comes nearly two years after Dana-Farber Cancer announced it was retracting six studies and correcting 31 others, as local scientists faced "data forgery" allegations for their cancer research.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
